Cataract Treatment Gets More Precise with FDA Approval of Softec HD™ Lens
New Intraocular Lens (IOL) Implant from Lenstec Enables Surgeons to Achieve Unmatched Precision and Predictability St. Petersburg, Florida – April 6, 2010 — Lenstec, Inc. — a manufacturer of technologically-advanced implantable lenses – today announced that the U.S. Food and Drug Administration has approved the company’s Softec HD™ Intraocular Lens Implant (IOL) for treating patients with … [read more]
Lenstec Gains FDA Approval for Softec HD™ IOL to Treat Cataracts
New Intraocular Lens Implant Enables Surgeons to Achieve Unmatched Precision and Predictability St. Petersburg, Florida – April 5, 2010 — Lenstec, Inc. — a provider of technologically- advanced implantable lenses – today announced that the U.S. Food and Drug Administration has approved the company’s Softec HD™ Intraocular Lens Implant (IOL) for treating patients with cataracts. The … [read more]
Lenstec Introduces Precision Series™ Intraocular Lens Implants
New Mono-Focal and Accommodating IOLs are Designed to Help Surgeons Treat Cataracts with Enhanced Precision and Predictability St. Petersburg, Florida – April 20, 2006 – Lenstec, Inc, — a provider of technologically- advanced lenses for treating vision disorders – today announced the introduction of its Precision Series™ intraocular lens implants (IOLs) for treating patients with cataracts. … [read more]